Internet Explorer is no longer supported by Microsoft. To browse the NIHR site please use a modern, secure browser like Google Chrome, Mozilla Firefox, or Microsoft Edge.

Parkinson's Portfolio Development Group


Published: 30 May 2019

Version: May2019/1.0

Print this document

Our mission

The Parkinson’s Portfolio Development Group (PDG) is composed of experienced researchers from diverse disciplines and lay members within the Parkinson’s field that promote the development of innovative ideas into funded research.

The remit, structure and governance of the Parkinson’s PDG are somewhat similar to their predecessor, the Clinical Studies Groups. Broadly, it includes identifying research gaps as well as supporting Writing Groups to formulate and prepare grant applications for clinical studies and health and social care research; including research conducted outside of NHS settings.


The Parkinson’s PDG meets twice yearly, face to face, with additional subgroups and working parties established as required. These are coordinated by the Office of the National Director for Dementia Research, Professor Martin Rossor, in alignment with the Clinical Research Network, and funded by the NIHR and medical research charities.

Who we are


Monty Silverdale, Consultant Neurologist at Greater Manchester Neuroscience Centre, Salford Royal NHS Foundation Trust


Dag Aarsland, Professor of Old Age Psychiatry, King's College London

Khaled Amar, Consultant Physician, Royal Bournemouth Hospital

Oliver Bandmann, Professor of Movement Disorders Neurology and Honorary Consultant Neurologist, University of Sheffield

Yoav Ben-Shlomo, Professor of Clinical Epidemiology, University of Bristol

Camille Carroll, Associate Professor and Honorary Consultant Neurologist, Plymouth Hospitals NHS Trust

Ray Chaudhuri, Professor of Movement Disorders, King's College London

Carl Clarke, Professor of Professor of Clinical Neurology, University of Birmingham, Sandwell and West Birmingham Hospitals NHS Trust

Helen Dawes, Director of Centre for Movement, Occupational and Rehabilitation Sciences Oxford Brookes University

Jonathan Evans, Consultant Neurologist, Nottingham University Hospitals NHS Trust

Tom Foltynie, Professor of Movement Disorders, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust

Donald Grosset, Professor of Movement Disorders, NHS Greater Glasgow and Clyde, and Honorary Senior Lecturer in Neurology, University of Glasgow

Annette Hand, Nurse Consultant, Northumbria Healthcare NHS Foundation Trust

Emily Henderson, Consultant Geriatrician, Royal United Hospitals Bath NHS Foundation Trust and Honorary Consultant Senior Lecturer, University of Bristol

Michele Hu, Associate Professor and Consultant Neurologist, Nuffield Department of Clinical Neurosciences, University of Oxford

Amelia Hursey, Research Participation Lead, Parkinson’s UK

Nin Bajaj, Consultant Neurologist, University of Nottingham

Natalie Ives, Assistant Director of the Birmingham Clinical Trials Unit, University of Birmingham

Helen Matthews, Deputy Chief Executive Officer, The Cure Parkinson’s Trust

Sophie Molloy, Consultant Neurologist, Imperial College Healthcare NHS & London North West University Healthcare NHS Trust

Peter Moore, Consultant Neurologist, The Walton Centre NHS Foundation Trust, Honorary Senior Lecturer in Neurology, Liverpool University

Huw Morris, Consultant Neurologist and Professor of Clinical Neuroscience, Royal Free Hospital and National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust and University College London

Alastair Noyce, Parkinson's UK Doctoral Research Fellow, University College London

Marios Politis, Professor of Neurology & Neuroimaging, Consultant Neurologist, and Director of Neurodegeneration Imaging Group, King’s College London and King’s College Hospital

Arthur Roach, Director of Research, Parkinson’s UK

Lynn Rochester, Professor of Human Movement Science and Director of Clinical Ageing Research Unit, Newcastle University

Mike Samuel, Consultant Neurologist, King's College Hospital

Anette Schrag, Professor of Clinical Neurosciences, University College London

Malcolm Steiger, Consultant Neurologist, Honorary Lecturer, University of Liverpool, Director of Research and Development, The Walton Centre NHS Foundation Trust

Richard Walker, Consultant Geriatrician and Honorary Professor of Ageing & International Health, Northumbria Healthcare NHS Foundation Trust

Rimona Weil, Wellcome Clinical Research Career Development Fellow, University College London and Honorary Consultant Neurologist, National Hospital for Neurology and Neurosurgery

Richard Windle, lay member, person with Parkinson’s, Supporter of Parkinson’s UK and The Cure Parkinson’s Trust

Paul Worth, Consultant in Neurology, Cambridge University Hospitals NHS Foundation Trust

Writing group support

Writing groups are time-limited groups comprising of researchers who wish to collaborate to take a research idea into a submitted grant proposal. Expressions of interest from researchers interested in applying to Writing Groups’ support are now being accepted. Support offered includes practical advice over expertise, applicants, patient involvement and study design, as well as logistic support for writing group meetings and post-award advice.

If you have an idea with the potential to advance clinical knowledge of Parkinson’s Disease in the UK and are interested in receiving support from the Parkinson’s Disease PDG, please email:

We aim to assess and provide feedback on whether the Parkinson’s Disease PDG can support your proposal within one week of submission. Please contact us if you have not heard within this timeframe.